Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec Earns Boehringer Pain Milestone | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Evotec Earns Boehringer Pain Milestone

Evotec AG has advanced a compound in its strategic alliance with Boehringer Ingelheim into Phase I clinical studies.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Evotec AG has advanced a compound in its strategic alliance with Boehringer Ingelheim into Phase I clinical studies. Evotec will receive a $2.5 million milestone payment as a result. The compound was discovered and optimized within the alliance and is being developed as a treatment for neuropathic pain.

The alliance has involved multiple high priority targets across key therapeutic areas and was recently expanded for four additional years to include oncology. To date, it has resulted in eight milestone payments from multiple programs.

Dr. Werner Lanthaler, chief executive officer of Evotec, said, “This clearly validates our strategy of creating value for our partners and further emphasizes our expertise in providing most efficient integrated drug discovery solutions for our collaborators. We are looking forward to advancing other exciting projects towards the clinic as part of this innovative alliance.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics